Page 8 - CUA 2020_Functional Urology
P. 8

Unmoderated Posters 3: Prostate Cancer, Functional Urology, Other Urology Topics






         UP-3.9. Table 2. Univariable and multivariable association for recurrence-free survival
                                   Recurrence-free survival (univariate)    Recurrence-free survival (multivariate)
         Parameter          Hazard ratio  95% hazard ratio     p      Hazard ratio  95% hazard ratio     p
                                            confidence                                confidence
                                              Limits                                   Limits
         Tumor grade           2.77      2.29       3.35     <0.0001     2.04      2.04      2.86      <0.0001
         Tumor margin          3.06      2.28       4.11     <0.0001     2.15      1.62      2,86      <0.0001
         Tumor size            1.05      1.03       1.07     <0.0001     1.05      1.03      1.06      <0.0001
         Adrenalectomy         1.5       1.23       1.82     <0.0001     1.07      0.85      1.35       0.55
        Conclusions: In this contemporary cohort, incidental adrenalectomy   standard computerized tomography (CT) or magnetic resonance imaging
        was not associated with better outcomes and likely reflect the more   (MRI) have adequately identified IVC extension, however, proximal extent
        advanced disease characteristics in this group. Adrenal sparing surgery   can be underestimated. Accurate and timely assessment of tumor thrombus
        should remain the standard of care when technically feasible and in the   staging is imperative prior to undertaking radical surgical resection. We
        absence of imaging abnormalities.                    aimed to assess the value of dual energy CT in the evaluation of IVC tumor
        References                                           thrombus in patients undergoing nephrectomy and IVC thrombectomy.
        1.   Leibovitch I, Raviv G, Mor Y, et al. Reconsidering the necessity   Methods: Four patients identified to have resectable IVC thrombus were
            of ipsilateral adrenalectomy during radical nephrectomy for renal   included in the pilot study. All patients had undergone standard CT at
            cell carcinoma. Urology 1995;46:316-20. https://doi.org/10.1016/  external imaging services and were reviewed independently. Contrast-
            S0090-4295(99)80213-1                            enhanced dual-energy CT was subsequently performed within seven days
        2.   Weight CJ, Kim SP, Lohse CM, et al. Routine adrenalectomy in   prior to planned resection using an adapted CT protocol. Virtual unen-
            patients with locally advanced renal cell cancer does not offer   hancement, blended-weighted average, and color-coded iodine overlay
            oncologic benefit and places a significant portion of patients at   reconstruction was performed. All images were then re-analyzed by a radi-
            risk for an asynchronous metastasis in a solitary adrenal gland. Eur   ologist, urologist, and trainee who were unaware of the original reports.
            Urol 2011;60:458-64. https://doi.org/10.1016/j.eururo.2011.04.022  Final determination of tumor thrombus level was made by consensus
        3.   Yap SA, Alibhai SMH, Abouassaly R, et al. Ipsilateral adrenalectomy   following intraoperative findings.
            at the time of radical nephrectomy impacts overall survival. BJU Int   Results: Fig. 1 demonstrates comparison between standard and dual-energy
            2013;111:E54-8. https://doi.org/10.1111/j.1464-410X.2012.11435.x  CT. The dual-energy CT results were accurate when compared to intraop-
        4.   Kutikov A, Piotrowski ZJ, Canter DJ, et al. Routine adrenalectomy   erative findings. Improved delineation of proximal extent of thrombus and
            is unnecessary during surgery for large and/or upper pole renal   involvement of IVC wall was seen compared to the initial standard CT.
            tumors when the adrenal gland is radiographically normal. J Urol   Conclusions: Dual-energy CT is a reliable imaging technique for evalua-
            2011;185:1198-203. https://doi.org/10.1016/j.juro.2010.11.090  tion of IVC tumor thrombus. Although there are few patients in the pres-
        5.   Weight CJ, Mulders PF, Pantuck AJ, et al. The role of adrenalec-  ent pilot, all cases showed accurate imaging findings when compared to
            tomy in renal cancer. Eur Urol Focus 2016;1:251-7. https://doi.  final surgical pathological confirmation. Ongoing evaluation of imaging
            org/10.1016/j.euf.2015.09.005                    standard of care in IVC thrombus is essential to maintain an easily acces-
                                                             sible, cost-effective, and accurate staging technique.
        UP-3.10
        Dual-energy computerized tomography for enhanced evaluation   UP-3.11
        of renal cell carcinoma with inferior vena cava thrombus  The increasing use of renal tumor biopsy among Canadian
        Ellen O’Connor 1,2,3 , Brennan Timm , Joseph Ischia , Amy Baker , Damien   urologists: When physician perceptions matter most
                                                   4
                                1,2
                                          1
                                                                                   2,3
                                                                      1
                                                                                                         5
                                                                                              4
             1
        Bolton , Nathan L. Lawrentschuk 1,3                  Felix Couture , Rodney H. Breau , Adrian Fairey , Antonio Finelli , Daniel
                                                                                                 7
        1 Department of Surgery, University of Melbourne, Austin Health,   YC Heng , Luke T. Lavallée , Ricardo A. Rendon , Simon Tanguay ,
                                                                                                              8
                                                                                 2,3
                                                                    6
                        2
        Heidelberg, Australia;  Young Urology Research Organisation, (YURO),   Patrick Richard 1
        Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum   1 Department of Urology, Centre Hospitalier Universitaire de Sherbrooke,
                         3
                                                                               2
        Cancer Centre, Melbourne, Australia;  Department of Radiology, Austin   Sherbrooke, QC, Canada;  Department of Urology, University of Ottawa,
                                   4
        Health, Heidelberg, Australia                        Ottawa, ON, Canada;  Ottawa Hospital Research Institute, University
                                                                             3
        Introduction: Direct endovascular extension of tumor thrombus into the infe-  of Ottawa, Ottawa, ON, Canada;  Department of Urology, University
                                                                                      4
                                                                                       5
        rior vena cava (IVC) occurs in 4–10% of renal cell carcinomas. Traditionally,   of Alberta, Edmonton, AB, Canada;  Department of Urology, Princess
                                                             Margaret Hospital, Toronto, ON, Canada;  Department of Oncology,
                                                                                            6
                                                             Tom Baker Cancer Centre, Calgary, AB, Canada;  Department of Urology,
                                                                                              7
                                                             Dalhousie University, Halifax, NS, Canada;  Department of Urology,
                                                                                             8
                                                             McGill University Health Centre, Montreal, QC, Canada
                                                             Introduction: The role renal tumor biopsy (RTB) in the management of
                                                             small renal masses (SRMs) is progressively being recognized. While an
                                                             increasing number of studies assessing its role as a diagnostic tool are
                                                             becoming available, the use of RTB remains variable among patients
                                                             diagnosed with a SRM. Many factors may influence urologists on whether
                                                             to perform a RTB to help guide management. We aimed at identifying
                                                             factors associated with the use of RTB in the Canadian population diag-
                                                             nosed with a SRM.
                                                             Methods: Data from the Canadian Kidney Cancer information sys-
                                                             tem of 3371 patients diagnosed with a SRM (≤4 cm) between January
                                                             2011 and September 2019 was retrospectively reviewed. Patients were
                                                             stratified based on whether a RTB was performed prior to the primary
        UP-3.10. Fig. 1. Comparison of standard CT (above) to dual-energy CT (below).
                                                CUAJ • June 2020 • Volume 14, Issue 6(Suppl2)                S71
   3   4   5   6   7   8   9   10   11   12   13